GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Intercure Ltd (XTAE:INCR) » Definitions » Price-to-Owner-Earnings

Intercure (XTAE:INCR) Price-to-Owner-Earnings : (As of May. 08, 2024)


View and export this data going back to 2007. Start your Free Trial

What is Intercure Price-to-Owner-Earnings?

As of today (2024-05-08), Intercure's share price is ₪12.15. Intercure does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.


The historical rank and industry rank for Intercure's Price-to-Owner-Earnings or its related term are showing as below:

During the past 13 years, the highest Price-to-Owner-Earnings of Intercure was 394.74. The lowest was 19.16. And the median was 79.18.


XTAE:INCR's Price-to-Owner-Earnings is not ranked *
in the Drug Manufacturers industry.
Industry Median: 28.075
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

As of today (2024-05-08), Intercure's share price is ₪12.15. Intercure's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2023 was ₪0.46. Therefore, Intercure's PE Ratio for today is 26.41.

As of today (2024-05-08), Intercure's share price is ₪12.15. Intercure's EPS without NRI for the trailing twelve months (TTM) ended in was ₪0.16. Therefore, Intercure's PE Ratio without NRI for today is 77.39.

During the past 13 years, Intercure's highest PE Ratio without NRI was 205.00. The lowest was 9.01. And the median was 40.24.


Intercure Price-to-Owner-Earnings Historical Data

The historical data trend for Intercure's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Intercure Price-to-Owner-Earnings Chart

Intercure Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 159.38 35.53 -

Intercure Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Dec23
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 48.94 35.53 - - -

Competitive Comparison of Intercure's Price-to-Owner-Earnings

For the Drug Manufacturers - Specialty & Generic subindustry, Intercure's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Intercure's Price-to-Owner-Earnings Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Intercure's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Intercure's Price-to-Owner-Earnings falls into.



Intercure Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Intercure's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=12.15/-0.93
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Intercure  (XTAE:INCR) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Intercure Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Intercure's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Intercure (XTAE:INCR) Business Description

Traded in Other Exchanges
Address
85 Medinat ha-Yehudim Street, Herzliya, ISR, 4676670
Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. The products are distributed to hospitals, pharmacies, research, and government organizations.